Evidence map›Paper›PMID 35310141›Full record

ArticleFrontiers in pediatrics2021

Familial Periodic Fever, Aphthous Stomatitis, Pharyngitis and Adenitis Syndrome; Is It a Separate Disease?

Tamar Veres, Gil Amarilyo, Sabreen Abu Ahmad, Maryam Abu Rumi, Riva Brik, Nofar Hezkelo, Orly Ohana, Yoel Levinsky, Gabriel Chodick, Yonatan Butbul Aviel

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Tamar VeresThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Gil AmarilyoPediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Sabreen Abu AhmadThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Maryam Abu RumiThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Riva BrikDepartment of Pediatrics B, Rambam Medical Center, Ruth Rappaport Children's Hospital, Haifa, Israel.
Nofar HezkeloDepartment of Medicine F-Recanati, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Orly OhanaDepartment of Pediatrics C, Schneider Children's Medical Center, Petah Tikva, Israel.
Yoel LevinskyPediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Gabriel ChodickPediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Yonatan Butbul AvielThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Schneider Children's Medical Center · ILTechnion – Israel Institute of Technology · ILRabin Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA) is the most common periodic fever syndrome in the pediatric population, yet its pathogenesis is unknown. PFAPA was believed to be sporadic but family clustering has been widely observed. Objective: To identify demographic and clinical differences between patients with PFAPA and a positive family history (FH+) as compared to those with no family history (FH-). Methods: In a database comprising demographic and clinical data of 273 pediatric PFAPA patients treated at two tertiary centers in Israel, 31 (14.3%) had FH+. Data from patients with FH+ were compared to data from those with FH-. Furthermore, family members (FMs) of those with FH+ were contacted via telephone for more demographic and clinical details. Results: The FH+ group as compared to the FH- group had more myalgia (56 vs. 19%, respectively, Conclusions: Our findings suggest that patients with a FH+ likely experience a different subset of disease with higher frequency of family history of FMF, arthralgia, myalgia, and might have a better response to colchicine compared to FH-. Colchicine prophylaxis for PFAPA should be considered in FH+.

Indexed as

familyfeverhistoryMediterraneanPFAPA

Identifiers

PMID35310141
PMCPMC8929572
OpenAlexW4214852876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.